United Kingdom· GB-APID-36865511000001101
NexoBrid 5g powder and gel for gel vials
A medicinal product containing concentrate of proteolytic enzymes enriched in bromelain, registered in United Kingdom by MediWound GmbH.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Concentrate of proteolytic enzymes enriched in bromelain
- Manufacturer
- MediWound GmbH
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin7290012699092
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Concentrate of proteolytic enzymes enriched in bromelain in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyBromelain-PosUrsapharm Arzneimittel Gmbh
- CzechiaNEXOBRIDMediWound Germany GmbH, Rüsselsheim
- SwedenNexoBrid 2 g Pulver och gel till gelMediWound Germany GmbH
- PolandNexoBridMediWound Germany GmbH
- BelgiumNexobrid 2 gMediwound Germany
- SpainNEXOBRID 2 g polvo y gel para gelMediwound Germany Gmbh
- SwitzerlandNexoBrid, poudre et gel pour gelTriskel INTEGRATED SERVICES SA
- NorwayNexoBridMediWound Germany GmbH
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Germany · Bromelain-Pos, Bromelaintabletten Hysan
- Iceland · Nexobrid
- Liechtenstein · Nexobrid
- Norway · Nexobrid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ab6854b6-0b56-49f5-9278-ec4c7b836856 GET /v1/drugs/ab6854b6-0b56-49f5-9278-ec4c7b836856?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "36865511000001101",
"desc": "NexoBrid 5g powder and gel for gel vials (MediWound GmbH)",
"form": "Powder and gel for gel",
"vpid": "36865311000001107",
"source": "dmd",
"vtm_id": "33515611000001108",
"strength": "5 gram",
"substance": "Concentrate of proteolytic enzymes enriched in bromelain",
"ingredient": "Concentrate of proteolytic enzymes enriched in bromelain",
"supplier_code": "33523311000001106"
}See everything about concentrate of proteolytic enzymes enriched in bromelain.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.